Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Am J Transplant. 2012 Nov 21;13(1):157–166. doi: 10.1111/j.1600-6143.2012.04299.x

Table 2.

Baseline Characteristics of Younger (Age 18–64) and Older (Age ≥65) Adult Lung Transplantation Recipients

VARIABLE YOUNGER COHORT (n=4031) OLDER COHORT (n=774) P value
Age (years) 55.0 (45.0,60.0) 67.0 (65.0,69.0) <0.0001
Female 1758 (43.6) 246 (31.8) <0.0001
White 3363 (83.4) 695 (89.8) <0.0001
Greater than high school education (N miss=652) 1816 (45.1) 386 (49.9) 0.0467
Working for income 705 (17.5) 100 (12.9) <0.0001
LAS diagnosis group
 Group A (obstructive lung disease) 1627 (40.4) 291 (37.6) <0.0001
 Group B (pulmonary vascular disease) 172 (4.3) 20 (2.6)
 Group C (CF or immunodeficiency) 617 (15.3) 1 (0.1)
 Group D (restrictive lung disease) 1495 (37.1) 451 (58.3)
 Other 120 (3.0) 11 (1.4)
Primary disease specific diagnosis
 COPD/emphysema 1209 (30.0) 270 (34.9) <0.0001
 Idiopathic pulmonary fibrosis 1156 (28.7) 419 (54.1)
 Other 1666 (41.3) 85 (11.0)
%Predicted FEV, median 29.0 (19.0,48.0) 45.0 (27.0,62.0) <0.0001
%Predicted FVC, median 45.0 (35.0,58.0) 53.0 (41.0,65.0) <0.0001
Type of Lung Transplantation
 Single 1227 (30.4) 486 (62.8) <0.0001
 Double 2804 (69.6) 288 (37.2)
Disability level (KPS at transplantation)
 No assistance self-care (KPS 80–100) 652 (16.2) 127 (16.4) 0.0149
 Minimal assistance self-care (KPS 50–70) 2553 (63.3) 523 (67.6)
 Full assistance self-care (KPS 10–40) 826 (20.5) 124 (16.0)
BMI 24.7 (20.8,28.3) 26.1 (23.0,28.9) <0.0001
LAS at transplantation 37.7 (33.7,45.0) 39.0 (33.9,47.1) 0.0138
Days on waiting list 87.0 (26.0,270.0) 45.0 (16.0,135.0) <0.0001
Time to last follow-up or death (years) 2.7 (1.7,3.9) 2.0 (1.1,3.0) <0.0001

Values are summarized as number (percent) or median (25th, 75th percentile) and P values were obtained using Wilcoxon Rank Sums (continuous) and chi square (categorical) tests.

Abbreviations: Lung Transplantation (LT), Cystic fibrosis (CF), Lung allocation Score (LAS), Chronic Obstructive Pulmonary Disease (COPD), Forced Vital Capacity (FVC), Forced Expiratory Volume (FEV), Karnofsky Performance Score (KPS).

These recipients survived to 11 months after Lung Transplantation and had available Karnofsky Performance Score reported thereafter.